Lyon, France-based Medicrea reported its sales results for the third quarter of 2016, ending Sept. 30.
Here are six report highlights:
1. Medicrea sales totaled €6.8 million for the third quarter, representing a 3 percent decline compared to the same period in 2015. This decrease is due to a temporary decline in European activity.
2. In terms of 2016 year-to-date results, the company's sales have increased by 3 percent.
3. This year-to-date increase is due to the U.S. and France markets seeing sales increases of 9 percent and 13 percent, respectively.
4. The U.S. and France markets have witnessed growing popularity of Medicrea's UNiD patient-specific technology.
5. More than 100 surgeons use the UNiD patient-specific technology, and Medicrea expects to meet its 1,000 UNiD surgery milestone within the next month.
6. Medicrea is relocating its production facilities and office headquarters to its new site near Lyon. The company hopes this relocation into a single infrastructure will enhance productivity and collaboration.